4045-25: DNA-Driven Depression Relief: A Series of Case Studies Introducing the World of Psychiatric Pharmacogenomics
-
Register
- Non-member - $13
- Regular Member - $8
- Retired Member - $8
- Affiliate Member - $8
- Student Member - $8
- Military Member - $8
- International Member - $8
4045-25: DNA-Driven Depression Relief: A Series of Case Studies Introducing the World of Psychiatric Pharmacogenomics
Pharmacogenomic testing can help improve depression outcomes by predicting altered drug metabolism and response based on genetic differences between individuals. This presentation will explore the clinical application of pharmacogenomic testing with informative case studies. PMH nurses will learn how to leverage pharmacogenomics to deliver efficient care.
Presenters: Beth Kaskel, DNP, A-GNP-C, MSN, RN; Eveline Gwaabe, DNP, PMHNP-BC
Disclosures: The APNA planners and faculty have no relevant financial relationships to disclose. Off-label uses will not be discussed during this presentation.
Session Length: 45 minutes
Target Audience: RN, APRN
Learning Outcome:
Upon completion of this presentation, the participant will be able to:
- Explain at least two ways in which psychiatric pharmacogenomic testing can guide medication selection.
Key Takeaway(s):
- Consider implementing pharmacogenomic testing for patients most likely to benefit.
- Leverage pharmacogenomic education to confidently interpret genetic results and optimize treatment decisions.
Keywords: Depression, Pharmacogenomics, Pharmacology, Genetics
Nursing Continuing Professional Development:
0.75 pharmacology contact hours. * In order to receive contact hours, you must: Listen to the entire presentation, complete the reflection activity, evaluation, and honor statement before the expiration date. Once all steps are successfully completed, a certificate will be generated online and available for you to print immediately. Contact hours cannot be awarded unless all required components are completed.
The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Release Date: December 1, 2025
Access to this course will end: December 1, 2027
*For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.


are registered in the U.S. Patent and Trademark Office as trademarks of the American Psychiatric Nurses Association.